Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Facebook Stock Price: Can Facebook Avoid The Same Fate as Yahoo, RIM?

Page 1 of 2

Facebook Inc (FB)Facebook Stock Price: For Facebook Inc (NASDAQ:FB) investors, there is nothing worse than the thought of the social networking monster ending up in the same boat as Yahoo! Inc. (NASDAQ:YHOO) and Research In Motion Limited (NASDAQ:RIMM). When looking back at the past 12 months, it is easy to see that each company has had their fair share of bad days, although things may be beginning to look up for the trio.

The key difference to be aware of, however, is that Facebook is newest entrant into the publicly traded marketplace. Despite the fact that all three have shown somewhat of a recovery over the past three months, it is Facebook that has the most to lose (and gain) going forward.

Since its disastrous IPO in May, Facebook Inc (NASDAQ:FB)’s stock price has been all over the place. That being said, a 54% climb since September has brought forth some optimism. Its current price in the $27 range is a far cry from its opening IPO price. Of course, this is much better than where things stood during the heat of summer.

Do you recall the days when Research In Motion (RIM) was trading in the triple digits? This was four years ago, but many investors remember it like yesterday. Despite a monumental crash over the past couple of years, things are actually looking up for RIM. In the past three months alone, it is up a staggering 65% to right around $11-$12/share.

Yahoo, much like RIM, has seen better days. Although it was once a $35 stock, it is currently hovering around $19. Fortunately for investors in this company, shares are up almost 30% since September.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!